Research and Development
Bayer’s CRISPR venture opens for business in biotech hub
August 23, 2016 Manufacturing and Production, Research and Development Bayer, casebia, crispr, gene editing, gene-editing
Valeant appoints new executive VP of finance and CFO
August 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Valeant, appointment
FDA fast tracks Alzheimer’s drug from Lilly, AstraZeneca
August 22, 2016 Manufacturing and Production, Research and Development Alzheimer's disease, AstraZeneca, BACE, lilly, phase III
Doctors receiving drugmaker payments more likely to prescribe their products, BMJ study finds
August 22, 2016 Research and Development, Sales and Marketing
FDA delays appraisal of Sanofi, Zealand diabetes drug just days before decision due
August 22, 2016 Research and Development, Sales and Marketing NDA, Sanofi, appraisal, diabetes, iglarlixi, type 2, type-2, zealand
Intercept’s Ocaliva meets primary endpoint in Phase III trial for rare liver disease
August 18, 2016 Medical Communications, Research and Development intercept, ocaliva
Chinese investors plan $1 billion US biotech site
August 18, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
J&J loses Remicade patent fight, pledges to continue fight against biosimilars
August 18, 2016 Research and Development, Sales and Marketing Johnson and Johnson, Remicade, biosimilar, biosimilars, infliximab, patent
Pfizer’s Xalkori price drop secures NICE recommendation
August 18, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Pfizer, Xalkori, crizotinib, lung cancer
MSD joins Medivation race, says reports
August 18, 2016 Manufacturing and Production, Research and Development, Sales and Marketing MSD, Medivation, Merck, Pfizer, Sanofi, Xtandi, takeover
NICE says Afinitor and Imbruvica “may be removed” from Cancer Drugs Fund
August 18, 2016 Research and Development, Sales and Marketing Afinitor, Cancer Drugs Fund, Janssen, NICE, Novartis, imbruvica
Untested cancer drug suspected cause of three deaths at German alternative medicine centre
August 17, 2016 Research and Development 3-Bromopyruvate, Cancer, Germany, alternative medicine, patient deaths
GSK, Roche and Novo back $86 million immuno-oncology startup
August 17, 2016 Research and Development CD47, Cancer, GSK, Novo, Roche, Tioma, oncology
Amgen, Sanofi cholesterol medicines “not cost-effective”, need to drop price by two-thirds
August 17, 2016 Research and Development, Sales and Marketing Amgen, QALY, Regeneron, Repatha, Sanofi, cost effective, cost-effective, praluent
ViiV Healthcare launches Phase III trial for combo HIV treatment
August 16, 2016 Research and Development Dolutegravir, HIV, Tivicay, ViiV Healthcare, epivir, lamivudine, phase III
